Deborah Toner
Deborah Toner, Director of Regulatory Affairs, Veryan Medical
Deborah is a seasoned Regulatory Affairs leader in the medical devices sector, with responsibility for guiding regulatory strategy across both pre market and post market activities in a fast moving, highly regulated environment. She serves as Director of Regulatory Affairs at Veryan Medical, where she leads regulatory programs that support product development, market access, and sustained compliance throughout the device lifecycle.
With over 20 years of experience in the medical device industry, Deborah has built a broad and practical understanding of how regulatory requirements intersect with quality systems, clinical evidence generation, and product realization. Her career spans roles across a range of organizations from start-ups to large multinationals, including Teleflex Medical, PQ Bypass, Vasorum, and Boston Scientific, giving her exposure to diverse operating models and regulatory pathways. Across these roles, she has held positions involving both hands on regulatory execution and cross functional leadership, with experience in Regulatory Affairs, Quality Assurance, Clinical Affairs, Design Assurance, and Program Management.
Deborah’s technical foundation is supported by an MEng in Biomedical Engineering from Dublin City University, which underpins her ability to translate complex engineering and clinical concepts into clear regulatory strategies and robust evidence packages.
Beyond her company responsibilities, Deborah contributes to the broader MedTech community through active professional engagement. She has been an active member of the Irish Medtech Association for over a decade, supporting collaboration and best practice sharing across the Irish MedTech ecosystem. She also represents Veryan Medical on the MedTech Europe Regulatory Affairs Committee, participating in industry dialogue on evolving regulatory expectations and practical implementation challenges.
Recognized for balancing strategic oversight with executional rigor, Deborah is known for aligning regulatory direction with business priorities—while maintaining a strong focus on patient safety, compliance, and sustainable market access.